Fundraising FoxQTAS
2 known investors
Find your way into QTAS
Sign up to see every warm intro you have to QTAS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the QTAS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Qtas develops a quantum-sensor-based microscopy platform, described as the world's smallest MRI, that detects, sorts, and recovers intact individual rare cells (such as circulating tumor cells and rare immune cells) directly from unprocessed biological samples like whole blood or spinal fluid. The platform serves pharma, biotech, and liquid biopsy partners as an upstream tool feeding downstream molecular, genomic, proteomic, and single-cell analysis.
Investors · 2
Frequently asked questions
- What does QTAS do?
- Qtas develops a quantum-sensor-based microscopy platform, described as the world's smallest MRI, that detects, sorts, and recovers intact individual rare cells (such as circulating tumor cells and rare immune cells) directly from unprocessed biological samples like whole blood or spinal fluid. The platform serves pharma, biotech, and liquid biopsy partners as an upstream tool feeding downstream molecular, genomic, proteomic, and single-cell analysis.
- Who are QTAS's investors?
- QTAS's investors include Creative Destruction Lab (CDL), OVNI Capital.